Deep Learning, Nvidia, Ray Tracing, Amd, Intel.
$300-$500m is about the amount of money it takes develop a biotech drug. Tapeouts are much more predictable than they were (thank you EDA industry), but still a risk. The tapeout is like the phase 2 readout. If any of these deep learning startups miss on their tapeout, it is over. And if they have